Reuters logo
BRIEF-Kangmei Pharmaceutical subsidiaries to set up three wholly owned units
March 29, 2017 / 10:14 AM / in 8 months

BRIEF-Kangmei Pharmaceutical subsidiaries to set up three wholly owned units

March 29 (Reuters) - Kangmei Pharmaceutical Co Ltd :

* Says its Hong Kong-based unit will invest C$1 million to set up a wholly owned subsidiary in Toronto named Kangmei(Toronto) Health Technology Co Ltd, which will be engaged in R&D and selling business of American ginseng and other health foods

* Says its health unit will invest 100 million yuan to set up a wholly owned subsidiary in Guangzhou, which will be engaged in logistics warehousing and smart pharmacy business

* Says its information unit will invest 50 million yuan to set up a wholly owned subsidiary in Shenzhen, which will be engaged in factoring business

Source text in Chinese: goo.gl/Vwdl2E; goo.gl/Ddgdlq; goo.gl/Y1eh28

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below